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Purpose: The purpose of this study is to characterize the bacterial flora of the ocular and periocular 
surface in cataract surgery patients and to determine the prevalence of methicillin resistance among 
staphylococcal isolates obtained from health care workers (HCWs) and non-HCWs.
Methods: In this prospective, multicenter, case series study, eyelid and conjunctival cultures 
were obtained from the nonoperative eye of 399 consecutive cataract patients on the day of 
surgery prior to application of topical anesthetics, antibiotics, or antiseptics. Speciation and 
susceptibility testing were performed at the Dean A. McGee Eye Institute. Logistic regression 
was utilized to evaluate whether any factors were significant in predicting the presence of 
methicillin-resistant staphylococcal isolates.
Results: Staphylococcus epidermidis (62.9%), followed by S. aureus (14.0%), was the most 
frequently isolated organism. Methicillin-resistant S. epidermidis accounted for 47.1% (178/378) 
of S. epidermidis isolates, and methicillin-resistant S. aureus accounted for 29.5% (26/88) of 
S. aureus isolates. Methicillin-resistant staphylococcal isolates were found in 157 of 399 (39.3%) 
patients, the majority (89.2%) of whom were non-HCWs. The likelihood of being colonized 
with methicillin-resistant organisms increased with age (odds ratio [OR], 1.27; 95% confidence 
interval [CI]: 1.02–1.58; P = 0.04) but decreased with diabetes (OR, 0.51; 95% CI: 0.29–0.89; 
P = 0.02). Being a HCW (OR, 1.25; 95% CI: 0.61–2.58; P = 0.54) was not a risk factor for 
colonization with methicillin-resistant organisms.
Conclusion: Patients without exposure to health care environments are as likely as HCWs to 
be colonized with methicillin-resistant organisms. Increasing methicillin resistance with age 
may partially explain the increased risk of endophthalmitis reported with older age.
Keywords: age, bacterial flora, cataract surgery, methicillin resistance, ocular and periocular 
surface, Staphylococci
Introduction
The endogenous ocular and periocular bacteria flora serve as the predominant source 
of organisms leading to postoperative infection.1,2 In recent years, the incidence of 
endophthalmitis following cataract extraction has ranged from 0.015% to 0.25%.3–8 
Despite aggressive intervention, approximately half of all patients who develop acute 
postoperative endophthalmitis fail to achieve final visual acuity of 20/40 or better.9,10
Microorganisms from the ocular and periocular surface may enter the anterior 
chamber during cataract extraction, with reported rates of anterior chamber contamina-
tion as high as 43%.11–13 In addition, laboratory models of human cadaveric eyes have 
demonstrated fluid flow across clear corneal wounds, with the potential for bacterial 
entry in the early postoperative period explaining increased rates of endophthalmitis 
associated with clear corneal incisions.14,15 The Endophthalmitis Vitrectomy Study Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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demonstrated that the vast majority of cases of postcataract 
endophthalmitis arise secondary to Gram-positive organisms, 
including Staphylococcus epidermidis and S. aureus.14 
Although a similar spectrum of bacteria has been observed 
in subsequent studies of endophthalmitis,9,15,16 recent reports 
from tertiary care centers suggest changes in the antibiotic 
susceptibility patterns of these isolates with most causative 
organisms now being methicillin resistant.16,17
Methicillin-resistant S. aureus (MRSA), first reported in 
the 1960s,18,19 has now become one of the most common and 
devastating causes of bacterial infections in hospitals and 
intensive care units.20 In recent years, community-acquired 
MRSA has also emerged in otherwise healthy individuals 
without prior exposure to health care facilities.21–23 Of par-
ticular concern to ophthalmic surgeons is the rising number 
of reports of ocular infections secondary to both MRSA and 
methicillin-resistant S. epidermidis (MRSE).3,17,24–31 In addition 
to resistance to β-lactam antimicrobials, both nosocomial and 
community-acquired strains of MRSA and MRSE are becom-
ing increasingly multidrug resistant.3,29,32,33
Effective prophylactic strategies for reducing the risk 
of postoperative endophthalmitis, such as preoperative 
povidone–iodine application and the use of perioperative 
topical antibiotics, are specifically designed to reduce the bac-
terial flora on the ocular and periocular surface. Evaluating 
the bacteria present on the conjunctiva and eyelids and their 
sensitivities provides important information in determining 
a rational approach to the selection of antibiotics for surgical 
prophylaxis and treatment of ocular infections. This study 
was undertaken to characterize the bacteria present on the 
ocular and periocular surface in patients undergoing cataract 
extraction. In addition, the study was designed to determine 
the prevalence of methicillin resistance among staphylococ-
cal isolates cultured from individuals working in the health 
care industry and nonhealth care workers (non-HCWs) to 
determine if this remains a valid determinant of risk.
Methods
A prospective, multicentered study was conducted at 10 sites 
in the United States between December 2007 and August 
2008. Eyelid and conjunctival cultures were obtained from 
the nonoperative eye in 399 patients undergoing elective 
cataract surgery. The patients represented a consecutive 
series of patients from a single surgeon at each site who 
satisfied inclusion criteria. Cultures were performed on the 
day of surgery prior to the application of any topical anes-
thetics, antibiotics, or antiseptics. This study was initiated 
following approval by the Institutional Review Board at each 
of 10 study sites and was performed in compliance with the 
principles outlined in the Declaration of Helsinki and Health 
Insurance Portability and Accountability Act regulations. All 
patients who participated provided written informed consent 
prior to the initiation of study-related procedures. The trial is 
registered with the identifier NCT00621933 at http://www.
clinicaltrials.gov.
Patient eligibility was determined at a prior screening 
visit. Patients aged at least 50 years scheduled for cataract 
extraction were eligible for the study. Primary exclusion 
criteria included the use of any topical ocular or periocular 
antibiotics, antiseptics, or lid scrubs within 7 days of cataract 
surgery; the use of artificial tears or contact lenses on the 
day of surgery; or history of any ocular infection within the 
prior 3 months. At screening, a questionnaire was adminis-
tered in which the subjects were asked whether they were 
employed in a health care facility or directly cared for a 
person in a long-term care facility. Those who answered yes 
to this question were categorized as HCWs for purposes of 
analysis. An additional screening question was whether the 
subject had an immediate family member employed in a 
health care setting.
Two cultures were obtained on each patient using the 
BD CultureSwab® MaxV(+) Transport System (Becton, 
Dickinson and Company, Franklin Lakes, NJ). The superior 
eyelid was swabbed at the lash margin, followed by a swab 
of the inferior tarsal conjunctiva without touching the eyelid 
or lashes. Each unit is composed of a sterile peel pouch, 
containing a rayon-tipped swab applicator for collection, 
and a tube, containing transport medium, into which the 
swab applicator is placed following sampling. Samples 
were shipped overnight on the day of collection to a central 
laboratory at the University of Oklahoma Health Sciences 
Center, Dean A. McGee Eye Institute, for speciation and 
susceptibility testing.
speciation and susceptibility testing
Each swab of collected material was streaked for isolation on 
5% tryptic soy agar containing 5% sheep blood agar (VWR 
International Ltd., West Chester, PA). Isolated colonies were 
cultured in brain–heart infusion media for 18 h, and sterile 
glycerol was added to a final concentration of 15% for 
preparation of freezer stocks. Gram stains were performed 
by routine methods on all bacterial colonies. Gram-negative 
bacteria were speciated by the BBL® Enterotube™ II system 
(Becton, Dickinson and Company) following manufacturer Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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instructions. Briefly, the needle of the system was touched 
to an isolated colony and inserted into the Enterotube. 
Enterotubes were incubated overnight at 37°C. The positiv-
ity of colorimetric changes was scored and matched to the 
Enterotube database in order to speciate each Gram-negative 
isolate.
Gram-positive bacteria were tested for the presence 
of catalase using hydrogen peroxide (30%) to separate 
Staphylococcus species from other Gram-positive bacteria. 
Staphylococcus species were identified biochemically via 
colorimetric reactions using the API™ staph kit (bioMérieux, 
Inc., Durham, NC). Staphylococci were cultured in cation-
adjusted Müeller-Hinton broth + 2% NaCl (CA-MHB, VWR) 
overnight at 37°C. Suspensions were diluted in CA-MHB 
to a turbidity visually equivalent to that of a 0.5 McFarland 
standard. Diluted suspensions were added to the API staph 
kit according to manufacturer specifications. API strips were 
incubated overnight at 37°C. The colorimetric changes were 
scored and matched to the API database in order to speciate 
each Staphylococcal isolate.
Following speciation, Staphylococcus species were tested 
for susceptibility to oxacillin (OX) by the Etest® (bioMérieux, 
Inc.). By convention, oxacillin resistance is synonymous with 
resistance to methicillin. A suspension of the test strain equal 
to the visual turbidity of 0.5 McFarland standard was pre-
pared and swabbed onto a 100-mm-diameter plate containing 
10–15 mL of cation-adjusted Müeller–Hinton agar with 2% 
NaCl. The oxacillin-coated test strips were placed on each 
plate in accordance with the manufacturer’s instructions. 
Oxacillin concentrations on each strip ranged from 0.016 to 
256 µg/mL. The minimum inhibitory concentrations (MICs) 
were interpreted after 18–24 h of incubation in ambient air at 
37°C. The MICs were compared to the oxacillin MIC break-
points using the breakpoints defined by the Clinical Laboratory 
Standards Institute (CLSI), and the bacteria were categorized 
as susceptible or resistant. For S. aureus and S. lugdunensis, 
the oxacillin MIC breakpoints were #2 µg/mL (sensitive) and 
$4 µg/mL (resistant). For coagulase-negative Staphylococci 
other than S. lugdunensis, the oxacillin MIC breakpoints were 
#0.25 µg/mL (sensitive) and $0.5 µg/mL (resistant). The 
lowest drug concentration that inhibited 90% of strains tested 
was recorded as the MIC90. Oxacillin testing was not performed 
if the species failed to grow out of stock.
statistical analysis
Multivariate logistic regression with forward stepwise selec-
tion was performed to evaluate the associations of the binary 
nominal dependent variable ‘presence of methicillin-resistant 
Staphylococcus’ with the continuous or categorical indepen-
dent variables of age (by decade), race, status as a HCW, rela-
tive of a HCW, and history of diabetes mellitus or glaucoma. 
Ninety-five percent confidence intervals (95% CIs) and odds 
ratios (ORs) were presented. All P values were two-sided and 
were considered statistically significant when the values were 
,0.05. The significant variables were modeled alone and in 
combination against the dependent variable, and the good-
ness of fit of the model was evaluated using the Hosmer and 
Lemeshow r2 test. All analyses were carried out using SAS 
(version 9.1;SAS Institute Inc., Cary, NC).
Results
Baseline demographics of the 399 cataract surgery patients 
enrolled in this study are shown in Table 1. Of the 399 
patients, 38 (9.5%) worked within the health care industry 
and were classified as HCWs. Fifteen of the HCWs and 68 
of the non-HCWs also had an immediate family member 
employed in the health care industry.
Cultures were positive in 80.5% (321/399) of the eyelid 
samples and in 57.4% (229/399) of the conjunctival samples 
obtained from the nonoperative eye at the time of cataract 
surgery. Bacterial growth of more than one strain or species 
was seen in 18.7% (60/321) of the eyes with positive eyelid 
cultures and in 10.0% (23/229) of the eyes with positive con-
junctival cultures. The vast majority of the organisms isolated 
Table 1 Baseline patient demographics of 399 cataract surgery 
patients
Number (%)
gender
  Female 224 (56.1)
Age, years
  Mean (sD) 69.5 (10.2)
  Median (rangea) 70 (24–97)
race, n (%)
  Caucasian 347 (87.3)
  African American 15 (3.6)
  hispanic/Latino 27 (6.6)
  Asian/Pacific Islander 6 (1.5)
  Other 4 (1.0)
Comorbidities, n (%)
  glaucoma 35 (8.8)
  Diabetes 83 (20.9)
  glaucoma and diabetes 10 (2.5)
health care facility exposure
  health care worker (hCW) 38 (9.5)
  Family member of a health care worker 83 (20.8)
Note: asix patients were protocol violations based on age criterion alone.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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from both the eyelids and conjunctiva were Gram-positive 
species (Figure 1). S. epidermidis was the most frequently 
isolated organism, accounting for 61.8% (243/393) of the 
eyelid isolates and 64.5% (165/256) of the conjunctival 
isolates, followed by S. aureus, which accounted for 15.3% 
(60/393) of the eyelid isolates and 12.1% (31/256) of the 
conjunctival isolates.
The oxacillin (methicillin) susceptibility patterns of 
539 staphylococcal isolates (331 eyelid and 208 conjunctival 
species) are shown in Figure 2. Overall, oxacillin (methicil-
lin) resistance was seen in 222 of the 539 (41.2%) isolates. 
A similar percentage of oxacillin (methicillin) resistance was 
seen in the staphylococcal isolates obtained from both the lids 
(42.9%) and the conjunctiva (38.5%). Of 378 S. epidermidis 
isolates tested from the lid and conjunctiva, 178 (47.1%) 
were oxacillin (methicillin) resistant and categorized as 
MRSE. Of the 88 S. aureus isolates tested, 26 (29.5%) were 
oxacillin (methicillin) resistant and categorized as MRSA. 
The distribution of oxacillin (methicillin) resistance based 
on the specific site locations is shown in Table 2.
Overall, oxacillin (methicillin)-resistant staphylococcal 
isolates of either the lid or conjunctiva were obtained from 
157 of the 399 (39.3%) patients. The majority (89.2%) of 
these patients with oxacillin (methicillin)-resistant isolates 
were categorized as non-HCWs. Based on HCW status, the 
percentage of staphylococcal isolates categorized as oxacillin 
(methicillin) resistant was similar in the HCWs (40.7%) and 
non-HCWs (41.2%). The MICs for the 26 MRSA isolates 
and the 178 MRSE isolates are listed in Table 3, separated 
by HCW status.
Table 4 shows the associations of various baseline 
characteristics and potential risk factors with the presence 
of methicillin-resistant staphylococcal isolates on the ocu-
lar or periocular surface. On logistic regression, only age 
(P = 0.04) and diabetes mellitus (P = 0.02) were statistically 
significant factors influencing ocular and periocular surface 
colonization. While increasing age (OR, 1.27 per decade; 
95% CI: 1.02–1.58) beginning at the sixth decade was asso-
ciated with an increase in ocular surface colonization with 
methicillin-resistant organisms, the diagnosis of diabetes 
Lid
(N = 393)
n = 243 (62%)
S. epidermidis
n = 60 (15%)
n = 18 (5%)
n = 12 (3%)
n = 9 (2%)
n = 9 (2%)
n = 7 (2%) n = 21 (5%)
n = 14 (4%)
S. aureus
Micrococcus species
S. xylosus
S. warneri
S. lugdunensis
S. capitis
Other Gram-positive
bacteriaa
Gram-negative bacteriab
Figure 1A Bacterial species on the lids and conjunctiva of cataract surgery patients.
Notes: aincluded S. hominis (n = 6; 1.5%), S. saprophyticus (n = 3; 0.8%), Streptococcus species (n = 3; 0.8%), S. sciuri (n = 2; 0.5%), S. lentus (n = 2; 0.5%), S haemolyticus (n = 2; 0.5%), 
S. caprae (n = 2; 0.5%), and S. cohnii spp urealyticus (n = 1; 0.3%); bincluded Enterobacter agglomerans (n = 5; 1.3%), Serratia marcescens (n = 2; 0.5%), Kiebsiella ozaenae (n = 2; 0.5%), 
Enterobacter aerogenes (n = 1; 0.3%), Escherichia coli (n = 1; 0.3%), Acinetobacter lwoffii (n = 1; 0.3%), Kocuria varianslrosea (n = 1; 0.3%), and Shigella (n = 1; 0.3%).Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Lid
S. epidermidis (n = 224)a
S. aureus (n = 59)a
S. warneri (n = 8)a
S. lugdunensis (n = 9)
S. capitis (n = 6)
S. hominis (n = 4)
S. caprae (n = 2)
S. lentus (n = 1)
S. sciuri (n = 1)
S. cohnii spp urealyticus (n = 1)
S. haemolyticus (n = 2)
S. saprophyticus (n = 2)a
S. xylosus (n = 12)
02 04 06 08 0 100
100%
100%
100%
100%
50%
50%
50%
83%
88%
66%
33%
17%
58%
42%
59%
51%
48%
34%
0%
0%
0%
0%
0%
0%
Percentage of Staphylococcus species
Oxacillin resistant
Oxacillin susceptible
Figure 2A Oxacillin (methicillin) susceptibility of lid and conjunctival Staphylococcus species.
Notes: aFour (7%) S. aureus isolates, 2 (1.O%) S. epidermis isolates, 1 (50%) S. saprophyticus isolate, and 1 (12%) S. warneri isolate were intermediately resistant to oxacillin.
Conjunctiva
(N = 256)
n = 13 (5%)
n = 7 (3%)
n = 6 (2%)
n = 6 (2%)
n = 12 (5%)
n = 9 (5%)
n = 7 (3%)
n = 165 (64%)
S. epidermidis
n = 60 (12%)
S. aureus
Micrococcus species
S. warneri
S. lugdunensis
S. capitis
Other Gram-positive
bacteriaa
Other Gram-negative
bacteriab
Enterobacter
agglomerans
Figure 1 B Bacterial species on the lids and conjunctiva of cataract surgery patients.
Notes: aincluded S. hominis (n = 4; 1.6%), S. caprae (n = 3; 1.2%), S. haemolyticus (n = 3; 1.2%), S. xylosus (n = 2; 0.8%); bincluded Kocuria varians/rosea (n = 2; 0.8%), Kocuria 
kristinae (n = 1; 0.4%), Enterobacter aerogenes (n = 1; 0.4%), Enterobacter cloacae (n = 1; 0.4%), Klebsiella pneumoniae (n = 1; 0.4%), Serratia marcescens (n = 1; 0.3%).
mellitus (OR, 0.51; 95% CI: 0.29–0.89) was associated with 
a lower prevalence of methicillin-resistant staphylococcal 
isolates. A detailed listing of the percentage of patients with 
methicillin-resistant staphylococcal isolates by decade is 
shown in Table 5.
Discussion
The present study was designed to characterize the surface 
flora of patients undergoing cataract surgery and to assess 
the prevalence of methicillin-resistant staphylococcal 
isolates present on the ocular and periocular surface. Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Resistance to methicillin and other β-lactams originates 
from the production of an altered penicillin-binding protein 
(PBP2a) encoded by the mecA gene. The term ‘methicil-
lin resistance’ is still used to describe staphylococcal 
isolates resistant to β-lactam antibiotics, despite the fact 
that oxacillin has replaced methicillin for purposes of 
laboratory testing. While methicillin-resistant infections 
were originally associated with hospitalized patients, 
community-acquired strains arose in the 1990s in patients 
without prior health care-related exposures and are becom-
ing increasingly common.
It is well established that postoperative endophthalmitis 
most commonly develops from ocular entry of endogenous 
bacteria from the ocular and periocular surface.1,2 Consistent 
with prior reports, the vast majority of isolates identified in 
the present study were Gram-positive organisms, specifically 
S. epidermidis and S. aureus.34–37 More importantly, methicil-
lin resistance was detected in 47.1% of the S. epidermidis 
isolates and 29.5% of the S. aureus isolates. This high rate 
of methicillin resistance in lid and conjunctival isolates is 
consistent with the rising rates of ocular infections reported 
secondary to MRSA and MRSE.
Although MRSA typically represented ,5% of all 
S. aureus ocular infections in the 1990s,27,29 The Surveil-
lance Network data set revealed that the proportion of 
MRSA among S. aureus-related serious ocular infections 
had climbed to 41.6% by 2005.24 Furthermore, Deramo et al 
reported MRSA in 6 of 33 (18.2%) culture-positive cases 
of endophthalmitis,17 and Miller et al noted that MRSE 
accounted for 52 out of 86 (60.5%) cases of S. epidermidis 
Table 2 Distribution of oxacillin (methicillin)-resistant Staphylococcus isolates by study sites
Lid Staphylococcus Conjunctival Staphylococcus
No. of isolates No. of resistant isolates (%) No. of isolates No. of resistant isolates (%)
Alexandria, LA 25 13 (52.0) 15 9 (60.0)
Austin, TX 9 6 (66.7) 9 3 (33.3)
Boston, MA 34 17 (50.0) 19 8 (42.1)
Charleston, sC 38 16 (42.1) 31 7 (22.6)
indianapolis, in 41 15 (36.6) 25 6 (24.0)
Long island, nY 37 13 (35.1) 21 7 (33.3)
Los Angeles, CA 25 9 (36.0) 7 2(28.6)
Miami, FL 45 17 (37.8) 21 9 (42.9)
salt Lake City, UT 35 21 (60.0) 32 16 (50.0)
Wilkes-Barre, PA 42 15 (35.7) 28 13 (46.4)
Total 331 142 (42.9) 208 80 (38.5)
Conjunctiva
S. epidermidis (n = 154)a
S. aureus (n = 29)a
S. warneri (n = 5)
S. lugdunensis (n = 5)
S. capitis (n = 4)
S. hominis (n = 3)
S. caprae (n = 3)a
S. haemolyticus (n = 3)
S. xylosus (n = 2)
02 04 06 0 80 100
33%
33%
67%
75%
25%
21%
100%
100%
100%
100%
70%
52%
45%
0%
0%
0%
0%
Percentage of Staphylococcus species
Oxacillin resistant
Oxacillin susceptible
Figure 2B Oxacillin (methicillin) susceptibility of lid and conjunctival Staphylococcus species.
Notes: aFour (3%) S. epidermis isolates, 1 (3%) S. aureus isolate, and 1 (33%) S. caprae isolate were immediately resistant to oxacillin.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1511
MrsA in cataract patients
endophthalmitis.10 From recent reports, it has also become 
evident that MRSA and MRSE ocular infections are no longer 
confined to HCWs and patients with exposure to long-term 
care facilities.30
In the United States, the frequency of both systemic and 
ocular methicillin-resistant staphylococcal infections in com-
munity settings is on the rise.25,38,39 In the present study, 89% 
of patients colonized with methicillin-resistant staphylococcal 
isolates were non-HCWs. More importantly, the percentage 
of staphylococcal isolates found to be methicillin-resistant 
was similar between HCWs and non-HCWS (40.7% ver-
sus 41.2%, respectively). Genetically confirmed strains of 
community-acquired methicillin-resistant Staphylococcus 
(USA 300 clone), which are most commonly associated with 
skin and soft-tissue infections, have now been reported in the 
ophthalmic literature in association with lid abscesses, orbital 
cellulitis, endophthalmitis, panophthalmitis, and superior 
ophthalmic vein thrombosis.40
In the present study, age (P = 0.04) was found to be a sig-
nificant risk factor contributing to increased rates of methicil-
lin resistance. This increase in ocular surface colonization with 
resistant bacteria in adults may result from greater exposure 
to antibiotics, changes in meibomian gland secretions, an 
increased likelihood of lacrimal duct obstruction, cumulative 
episodes of contact with health care settings, or a weakened 
immune response.41–45 This rise in the rate of colonization 
with methicillin-resistant species was particularly dramatic in 
patients aged 80 years and older. Higher prevalence of methi-
cillin resistance with increasing age may partially explain the 
findings of several recent population-based studies in which 
older age was associated with a greater risk for endophthal-
mitis.8,46 Relative to methicillin-sensitive staphylococcal spe-
cies, MRSA and MRSE are less likely to be eradicated with 
typical prophylaxis regimens and may lead to infection upon 
contamination with even a small inoculum.47
In contrast to prior reports in which diabetes, often 
insulin-dependent diabetes, has been identified as a risk 
factor for both MRSA colonization as well as infections,48–52 
patients with diabetes in the current study were less likely to 
be colonized with resistant organisms. One possible explana-
tion may be the increased importance of hygiene and skin care 
in diabetics due to their greater risk of infection in general. 
Alternatively, this finding may have occurred due to the fact 
that this was a patient self-reported diagnosis or as a result of 
our classification of both insulin-dependent and noninsulin-
dependent diabetic patients within a single category.
Understanding the type of bacteria present on the ocular 
surface allows ophthalmic surgeons to devise strategies 
to reduce the surface flora more effectively. Although the 
strongest evidence supports the preoperative application of 
povidone–iodine as an endophthalmitis prophylaxis regi-
men,3,53 multiple studies have demonstrated enhanced bacte-
rial surface eradication with the use of preoperative topical 
antibiotics in addition to povidone–iodine.54,55 As a result of 
Table 5 Correlation of patient age and rate of   methicillin-resistant 
ocular and periocular surface flora
Age group (yrs) No. of patients Percentage of patients 
with methicillin-resistant 
surface flora
,50 6a 0%
50–59 61 29.5%
60–69 126 33.3%
70–79 138 34.0%
80–89 60 48.3%
90–99 8 50.0%
Table 3 Distribution of oxacillin (methicillin)-resistant Staphylococcal 
isolates based on status as a health care or nonhealth care worker
Nonhealth care 
workers
Health care 
workers
Total
MrsA
  no. of isolates 25 1 26
  Oxacillin MiC (µg/mL)
    Median .256 4a .256
    MiC90 .256 4a .256
    range 16–.256 4–4 4–.256
Mrse
  no. of isolates 159 19 178
  Oxacillin MiC (µg/mL)
    Median 96 192 96
    MiC90 .256 .256 .256
    range 0.5–.256 0.5–.256 0.5–.256
Note:  aThis number corresponds to an MiC100 based on a single MrsA isolate 
tested from a health care worker.
Abbreviations: MrsA, oxacillin (methicillin)-resistant S. aureus; MiC, minimum 
inhibitory concentration; Mrse, oxacillin (methicillin)-resistant S. epidermidis; 
median, the middle MiC value in the ordered array of MiC values.
Table 4 effect of potential factors on the prevalence of methicillin-
resistant Staphylococcal ocular surface isolates
Factor OR (95% CI) P value
health care worker 1.25 (0.61–2.58) 0.54
relative of health care worker 0.73 (0.43–1.26) 0.26
Agea 1.27 (1.02–1.58) 0.04
Diabetes mellitus 0.51 (0.29–0.89) 0.02
glaucoma 1.44 (0.69–3.00) 0.33
Note: aAge was evaluated in the model based on incremental increases by decade 
from the sixth through the tenth decade.
Abbreviations: OR, odds ratio; CI, confidence interval. Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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their broad-spectrum activity, fluoroquinolones (FQs) are 
currently the topical antibiotics most commonly used in the 
United States in the perioperative setting. The potency of 
FQs against MRSA and MRSE isolates is often compared 
based on in vitro MICs of their active agents and in relation 
to serum CLSI standards developed for systemic adminis-
tration.10,56 However, these tests may not accurately account 
for the potentially higher antibiotic concen  trations achieved 
with topical dosing on the ocular surface that may eradicate 
some ‘resistant’ organisms.54,55 In addition, these tests may 
fail to reflect enhanced antibiotic activity achieved with the 
formulations prepared for ophthalmic use, including the 
presence of preservatives such as benzalkonium chloride, 
which may enhance antimicrobial activity of FQs even against 
FQ-resistant S. aureus.57,58
We acknowledge certain limitations in the present analy-
sis based upon the study design. All isolates were obtained 
from the nonoperative eye, and no assessments were made 
of the degree of surface sterilization following application 
of either povidone–iodine or antibiotics. In addition, despite 
a high degree of sensitivity and specificity, oxacillin test-
ing, as performed in the present study, ultimately remains 
a surrogate for detecting the mecA gene in the identification 
of resistant species of Staphylococcus.59 Furthermore, the 
categorization of HCWs and non-HCWs based on a ques-
tionnaire may not have fully separated patients as potential 
carriers of nosocomial versus community-acquired strains 
of resistant organisms. However, given that the carrier rates 
were comparable between groups, it is unlikely that misclas-
sification with respect to HCW status would have led to dif-
ferent conclusions. In order to further categorize the species 
isolated and better appreciate the potential risk these resistant 
isolates pose to patients, the susceptibility profiles against a 
full array of non-β-lactam antibiotics will be performed in a 
subsequent study.
In the present study, more than one-third of cataract 
surgery patients were colonized with methicillin-resistant 
Staphylococcus on their ocular or periocular surface. Given 
the rising rates of community-acquired methicillin-resistant 
Staphylococcus, history and clinical signs are no longer suf-
ficient to predict which patients will be colonized with MRSA 
or MRSE. In fact, this study demonstrated that individuals 
who did not work in the health care industry were just as 
likely as HCWs to be colonized with methicillin-resistant 
Staphylococcus. For these reasons, we suggest that all 
patients undergoing cataract surgery should be presumed 
to be colonized with methicillin-resistant organisms. In 
addition, the likelihood of being colonized with MRSA or 
MRSE increases directly with age, as does the incidence 
of endophthalmitis. We suggest that patient age is likely 
to become an important consideration in the design and 
implementation of prophylaxis regimens for all ophthalmic 
surgical procedures.
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